abagovomab 27
abciximab 27
abituzumab 22
abrilumab 19
actoxumab 16
adalimumab 20
aducanumab 14
afasevikumab 15
alacizumab_pegol 12
alemtuzumab 24
alirocumab 22
amatuximab 40
andecaliximab 22
anifrolumab 20
anrukinzumab 19
aprutumab 18
aprutumab_ixadotin 18
arcitumomab 24
ascrinvacumab 7
atezolizumab 16
atinumab 16
avelumab 14
basiliximab 27
bavituximab 37
begelomab 26
benralizumab 27
bevacizumab_beta 20
bezlotoxumab 16
bimagrumab 15
bleselumab 12
blinatumomab 32
blosozumab 29
bococizumab 17
brazikumab 18
brentuximab_vedotin 34
briakinumab 19
brodalumab 12
brolucizumab 26
brontictuzumab 27
burosumab 17
cabiralizumab 26
camrelizumab 15
canakinumab 23
cantuzumab_ravtansin 45
carlumab 13
carotuximab 29
cergutuzumab_amunaleukin2 26
cergutuzumab_amunaleukin 26
certolizumab_pegol 25
cetiximab 46
citatuzumab_bogatox 27
cixutumumab 27
clivatuzumab_tetraxetan 21
codrituzumab 29
conatumumab 11
concizumab 29
crenezumab 19
crizanlizumab 26
crotedumab 21
dacetuzumab 22
daclizumab 13
dalotuzumab 34
dapirolizumab_pegol 24
daratumumab 14
dectrekumab 10
demcizumab 24
denosumab 10
depatuxizumab 23
depatuxizumab_mafodotin 23
dezamizumab 21
dinutuximab 37
diridavumab 25
domagrozumab 17
drozitumab 16
duligotuzumab 21
durvalumab 8
dusigitumab 15
efalizumab 33
efungumab 30
eldelumab 16
elezanumab 22
elgemtumab 13
elotuzumab 17
emactuzumab 17
emapalumab 25
emibetuzumab 14
enavatuzumab 24
enfortumab_vedotin 14
enoblituzumab 20
enokizumab 25
enoticumab 20
ensituximab 32
eptinezumab 19
erenumab 22
etaracizumab 15
etrolizumab 22
evinacumab 22
evolocumab 16
farletuzumab 8
fasinumab 23
fezakinumab 21
fibatuzumab 12
ficlatuzumab 21
firivumab 34
flanvotumab 19
fletikumab 19
foralumab 14
foravirumab 16
fremanezumab 29
fresolimumab 17
fulranumab 20
futuximab 27
galcanezumab 21
ganitumab 26
gantenerumab 13
gemetuzumab 27
gemtuzumab2 25
gemtuzumab 22
gevokizumab 21
girentuximab 27
glembatumumab 17
glembatumumab_vedotin 17
guselkumab 23
ibalizumab 27
ibritumomab 35
icrucumab 12
idarucizumab 35
ifabotuzumab 12
imalumab 19
imgatuzumab 20
inclacumab 21
indatuximab_ravtansin 35
indusatumab 14
inebilizumab 22
intetumumab 14
iodine_girentuximab 29
ipilimumab 7
iratumumab 7
isatuximab 36
itolizumab 27
ixekizumab 31
labetuzumab_govitecan 19
lambrolizumab 26
lampalizumab 23
lanadelumab 18
landogrozumab 18
laprituximab 28
lebrikizumab 34
lendalizumab 23
lenzilumab 16
lifastuzumab_vedotin 25
ligelizumab 23
lilotomab 37
lirilumab 24
lodelcizumab 16
lokivetmab 25
lorvotuzumab_mertansin 26
lucatumumab 30
lumretuzumab 19
lupartumab 16
lutikizumab 20
margetuximab 33
milatuzumab 39
mirvetuximab 32
mirvetuximab_soravtansin 32
modotuximab 38
mogamulizumab 31
monalizumab 17
motavizumab 32
moxetumomab_pasudotox 32
namilumab 20
naratuximab 28
naratuximab_emtansin 28
narnatumab 16
navicixizumab2 28
navicixizumab 27
navivumab 34
necitumumab 12
nemolizumab 25
nesvacumab 17
nivolumab 13
obiltoxaximab 21
obinutuzumab 36
ocaratuzumab 27
ofatumumab 20
olaratumab 19
olokizumab 24
omalizumab 19
onartuzumab 22
ontuxizumab 22
opicinumab 14
orticumab 16
otelixizumab 37
oxelumab 13
ozanezumab 32
pamrevlumab 13
panobacumab 30
parsatuzumab 24
pasotuxizumab 23
pateclizumab 19
patritumab 19
pembrolizumab 26
perakizumab 23
pidilizumab 17
pinatuzumab_vedotin 19
plozalizumab 33
pogalizumab 23
polatuzumab_vedotin 22
ponezumab 38
prezalumab 16
pritoxaximab 37
quilizumab 21
racotumomab 28
radretumab 15
ralpancizumab 22
ramucirumab 14
ranevetmab 28
ranibizumab 23
refanezumab 22
remtolumab 20
rilotumumab 14
rinucumab 18
risankizumab 32
rituximab 21
rivabazumab 22
robatumumab 20
roledumab 34
romosozumab 18
rontalizumab 19
rosmantuzumab 21
rozanolixizumab 21
sacituzumab 29
sacituzumab_govitecan 29
samalizumab 26
sapelizumab 23
sarilumab 18
secukinumab 14
seribantumab 17
setoxaximab 41
sifalimumab 9
siltuximab 25
simtuzumab 26
sirukumab 12
solanezumab 27
solitomab 28
stamulumab 17
suptavumab 22
suvizumab 19
tabalumab 11
tadocizumab 19
tamtuvetmab 32
tanezumab 22
tarextumab 12
tavolixizumab 18
telisotuzumab 26
teplizumab 17
tesidolumab 22
tezepelumab 25
tigatuzumab 17
tildrakizumab 21
timolumab 14
tisotumab 15
tosatoxumab 39
tositumomab 32
tralokinumab 22
trastuzumab 24
tregalizumab 24
trevogrumab 13
ublituximab 28
urelumab 18
ustekinumab 29
utomilumab 26
vadastuximab 24
vadastuximab_talirin 24
vandortuzumab_vedotin 17
vantictumab 20
vanucizumab2 20
vanucizumab 27
varlilumab 17
vatelizumab 21
vedolizumab 24
veltuzumab 14
vesencumab 12
vorsetuzumab 20
vorsetuzumab_mafodotin 20
vunakizumab 30
xentuzumab 20
zatuximab 38
